OSENI |
022426 |
001 |
NDA |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 25MG BASE;EQ 15MG BASE |
Yes
|
No
|
2013/01/25
|
2013/01/25
|
TAKEDA PHARMS USA |
Prescription |
OSENI |
022426 |
002 |
NDA |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 25MG BASE;EQ 30MG BASE |
Yes
|
No
|
2013/01/25
|
2013/01/25
|
TAKEDA PHARMS USA |
Prescription |
OSENI |
022426 |
003 |
NDA |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 25MG BASE;EQ 45MG BASE |
Yes
|
Yes
|
2013/01/25
|
2013/01/25
|
TAKEDA PHARMS USA |
Prescription |
OSENI |
022426 |
004 |
NDA |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2013/01/25
|
2013/01/25
|
TAKEDA PHARMS USA |
Discontinued |
OSENI |
022426 |
005 |
NDA |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 12.5MG BASE;EQ 30MG BASE |
Yes
|
No
|
2013/01/25
|
2013/01/25
|
TAKEDA PHARMS USA |
Prescription |
OSENI |
022426 |
006 |
NDA |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2013/01/25
|
2013/01/25
|
TAKEDA PHARMS USA |
Discontinued |